000 01033 a2200301 4500
005 20250513165416.0
264 0 _c19990421
008 199904s 0 0 eng d
022 _a0277-0008
024 7 _a10.1592/phco.19.3.196.30913
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aRomanelli, F
245 0 0 _aHydroxyurea to inhibit human immunodeficiency virus-1 replication.
_h[electronic resource]
260 _bPharmacotherapy
_cFeb 1999
300 _a196-204 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnti-HIV Agents
_xpharmacology
650 0 4 _aClinical Trials as Topic
650 0 4 _aHIV Infections
_xdrug therapy
650 0 4 _aHIV-1
_xdrug effects
650 0 4 _aHumans
650 0 4 _aHydroxyurea
_xpharmacology
650 0 4 _aVirus Replication
_xdrug effects
700 1 _aPomeroy, C
700 1 _aSmith, K M
773 0 _tPharmacotherapy
_gvol. 19
_gno. 2
_gp. 196-204
856 4 0 _uhttps://doi.org/10.1592/phco.19.3.196.30913
_zAvailable from publisher's website
999 _c9992036
_d9992036